Recombinant Monodelphis domestica NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. However, if you have a specific format requirement, please indicate it in your order notes. We will accommodate your request if possible.
Lead Time
Delivery time may vary depending on the purchase method and location. Please consult your local distributor for specific delivery time information.
Note: All our proteins are shipped with standard blue ice packs by default. If you require dry ice shipping, please communicate with us in advance as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. For optimal preservation, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial prior to opening to ensure the contents settle at the bottom. Please reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%, which can be used as a reference.
Shelf Life
Shelf life is influenced by various factors including storage conditions, buffer components, temperature, and the inherent stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type is determined during production. If you have a specific tag type preference, please inform us, and we will prioritize developing the specified tag.
Synonyms
MT-ND4L; MTND4L; NADH4L; ND4L; NADH-ubiquinone oxidoreductase chain 4L; NADH dehydrogenase subunit 4L
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-98
Protein Length
full length protein
Species
Monodelphis domestica (Gray short-tailed opossum)
Target Names
Target Protein Sequence
MEQINLNMITAFTIALMGVLTYRSHLMSTLLCLEGMMLSLFILMVLLISHSHMVSMSMAP LILLVFSACEAGVGLALLVTISHTYGNDYVQNLNLLQC
Uniprot No.

Target Background

Function
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor.
Database Links
Protein Families
Complex I subunit 4L family
Subcellular Location
Mitochondrion inner membrane; Multi-pass membrane protein.

Q&A

What is the functional role of MT-ND4L in the mitochondrial respiratory chain?

MT-ND4L (Mitochondrially encoded NADH:Ubiquinone Oxidoreductase Core Subunit 4L) functions as an integral component of Complex I (NADH:ubiquinone oxidoreductase) in the mitochondrial respiratory chain. This protein participates in the electron transfer from NADH to ubiquinone, contributing to the generation of the proton gradient necessary for ATP synthesis. The protein is encoded by mitochondrial DNA and works in conjunction with other subunits to facilitate electron transport.

How does MT-ND4L from Monodelphis domestica differ from other mammalian species?

MT-ND4L from Monodelphis domestica (gray short-tailed opossum) represents an interesting evolutionary perspective as marsupials diverged from placental mammals approximately 160 million years ago. While maintaining the core functional domains necessary for electron transport, the Monodelphis domestica MT-ND4L exhibits specific amino acid variations that may influence its interaction with ubiquinone and other Complex I subunits.

Similar to observations in porcine mitochondrial studies, these variations may contribute to functional differences in biochemical traits including succinate dehydrogenase (SDH) activity, ATP production capacity, and susceptibility to reactive oxygen species (ROS) generation . Comparative sequence analysis using methods similar to those employed in studying porcine mitochondrial genomes would reveal the exact polymorphic sites that distinguish Monodelphis domestica MT-ND4L from other mammalian homologs.

What expression systems are most effective for producing recombinant MT-ND4L?

The expression of recombinant mitochondrial membrane proteins presents significant challenges due to their hydrophobic nature and normal mitochondrial localization. For MT-ND4L from Monodelphis domestica, several expression systems have demonstrated varying degrees of success:

  • Bacterial expression systems: Using an N-terminal His-tag fusion approach similar to that employed for Ndi1 expression in E. coli can yield functional protein . The protocol would involve:

    • Codon optimization for bacterial expression

    • Inclusion of a cleavable N-terminal His10 tag for purification

    • Expression in C41(DE3) or C43(DE3) bacterial strains designed for membrane protein expression

    • Extraction with either Triton X-100 or dodecyl-β-D-maltoside (DM) depending on experimental requirements

  • Yeast expression systems: S. cerevisiae or Yarrowia lipolytica systems may better accommodate the folding requirements of mitochondrial proteins.

  • Mammalian cell systems: Using transmitochondrial cybrid approaches as described for porcine mitochondrial studies can provide a more native-like environment for MT-ND4L expression and assembly into functional Complex I.

How can the ubiquinone binding domain of MT-ND4L be characterized using photoaffinity labeling techniques?

Characterization of the ubiquinone binding domain in MT-ND4L can be accomplished through photoaffinity labeling using photoreactive ubiquinone analogs. Based on successful characterization of the ubiquinone binding site in Ndi1 enzyme, the following methodological approach is recommended:

  • Synthesis of photoreactive ubiquinone mimics: Develop azido-Q derivatives following the principle of minimal modification of substituents on the quinone ring, such as 2-methoxy-3-azido-5-methyl-6-(alkyl tail)-1,4-benzoquinone structures with biotin tags for detection .

  • Photoaffinity labeling protocol:

    • Incubate purified recombinant MT-ND4L (0.1-0.3 mg/mL) with the azido-Q in buffer containing 50 mM MOPS-KOH (pH 7.0), 0.1 mM EDTA, and 10% glycerol for 10 minutes at room temperature

    • Perform UV irradiation with a long wavelength UV lamp for 10-20 minutes on ice

    • Quench the cross-linking by adding Laemmli's sample buffer or acetone precipitation

  • Identification of binding sites:

    • Digest the cross-linked protein with CNBr, V8 protease, or lysylendopeptidase

    • Separate fragments by Tricine/SDS-PAGE

    • Analyze cross-linked peptides using N-terminal sequencing and MALDI-TOF mass spectrometry

    • Compare results to predicted binding sites based on sequence alignment with known structures

This approach would identify specific amino acid residues involved in ubiquinone binding, providing insights into the electron transfer mechanism of MT-ND4L within Complex I.

How do mutations in MT-ND4L affect electron transfer kinetics and what are the implications for mitochondrial diseases?

Mutations in MT-ND4L can significantly alter electron transfer properties of Complex I, with profound implications for mitochondrial diseases. To investigate these effects:

  • Mutation analysis methodology:

    • Generate point mutations in recombinant MT-ND4L based on clinically identified variants

    • Incorporate mutant proteins into liposomes or transmitochondrial cybrids

    • Measure electron transfer rates using spectrophotometric assays at 340 nm (ε = 6.2 mM−1cm−1) in 50 mM NaPi buffer (pH 6.0) with 1 mM EDTA

  • Kinetic parameters to evaluate:

    • Km for NADH

    • NADH dehydrogenase activity

    • Ubiquinone-dependent electron transfer rates

    • Sensitivity to inhibitors like rotenone

Research on ND1 mutations indicates that some variants can exhibit up to 80% reduction in rotenone-sensitive and ubiquinone-dependent electron transfer activity while maintaining normal NADH dehydrogenase activity . Similar analyses for MT-ND4L mutations would reveal whether this subunit primarily affects ubiquinone interaction or has broader impacts on Complex I function.

The disease implications can be assessed by measuring:

  • ROS production levels

  • ATP synthesis capacity

  • Mitochondrial membrane potential

  • Cell viability under stress conditions

What role does MT-ND4L play in the assembly and stability of Complex I, and how can this be studied?

The role of MT-ND4L in Complex I assembly and stability can be investigated through a combination of biochemical and genetic approaches:

  • Assembly analysis techniques:

    • Pulse-chase labeling with radioactive amino acids to track the incorporation kinetics of MT-ND4L into Complex I

    • Blue Native PAGE to visualize assembly intermediates

    • Proximity labeling techniques to identify protein-protein interactions during assembly

  • Stability assessment methodology:

    • Thermal shift assays to determine the melting temperature of Complex I with wild-type versus mutant MT-ND4L

    • Limited proteolysis to identify regions protected through protein-protein interactions

    • Measurement of Complex I half-life under various stress conditions

  • Functional complementation studies:

    • Development of transmitochondrial cybrid models by fusion of cells devoid of mitochondrial DNA (ρ0 cells) with enucleated cytoplasm containing mitochondria with wild-type or mutant MT-ND4L

    • Assessment of biochemical traits including succinate dehydrogenase activity, ATP content, and ROS production in assembled complexes

The cybrid approach provides a particularly powerful tool for studying MT-ND4L's role in assembly, as it allows for the introduction of specific mitochondrial genomes into a consistent nuclear background, enabling direct comparison of how different MT-ND4L variants affect Complex I assembly and function.

What are the optimal conditions for measuring MT-ND4L activity within Complex I?

Measuring MT-ND4L activity within Complex I requires careful optimization of assay conditions to ensure reliable and reproducible results:

  • Preparation of functional protein:

    • Extract using mild detergents like dodecyl-β-D-maltoside (DM) to maintain native interactions with ubiquinone

    • Verify protein quality through SDS-PAGE and Western blotting

    • Determine FAD content spectroscopically to confirm proper cofactor integration

  • Optimal assay conditions:

    • Buffer composition: 50 mM NaPi buffer (pH 6.0) with 1 mM EDTA

    • Protein concentration: 0.066 μg/mL for spectrophotometric assays

    • Temperature: 30°C (standard) or 37°C (physiological)

    • Substrate concentration: 100 μM NADH for initiating the reaction

  • Activity measurement protocols:

    • Spectrophotometric monitoring of NADH oxidation at 340 nm (ε = 6.2 mM−1cm−1)

    • Ubiquinone reduction monitoring at 275 nm

    • Oxygen consumption measurements using Clark-type electrodes

    • ROS production assessment using fluorescent probes

  • Controls and validation:

    • Rotenone sensitivity to confirm Complex I-specific activity

    • Comparison with SDH activity to normalize for mitochondrial content

    • ATP synthesis coupling efficiency measurements

How can researchers generate transmitochondrial cybrids to study MT-ND4L variants?

The generation of transmitochondrial cybrids provides a powerful approach to study the functional effects of MT-ND4L variants. Based on methodologies used for porcine mitochondrial studies, the process involves:

  • Preparation of ρ0 recipient cells:

    • Introduce a selectable marker gene (such as GFP-neo) into recipient cells

    • Treat cells with rhodamine 6-G (R6-G) to deplete mitochondrial DNA

    • Confirm ρ0 status by:

      • Cell morphology observation (thin and flat appearance)

      • Dependence on uridine and pyruvate supplementation

      • Absence of Janus green B staining of mitochondria

  • Preparation of mitochondria donor cells:

    • Transfect donor cells containing the MT-ND4L variant of interest with mitochondria-targeted red fluorescent protein (MT-RFP)

    • Perform enucleation by treatment with cytochalasin B and centrifugation

    • Confirm enucleation through Giemsa staining

  • Cybrid formation:

    • Fuse ρ0 cells with enucleated cytoplasts using polyethylene glycol

    • Select cybrids based on:

      • G418 resistance (from recipient nuclear genome)

      • Growth in uridine/pyruvate-free medium (indicating functional mitochondria)

      • GFP fluorescence (nuclear marker) without RFP fluorescence (confirming enucleation)

  • Validation of cybrid lines:

    • Sequence mitochondrial DNA to confirm the presence of desired MT-ND4L variants

    • Measure mtDNA copy number to ensure comparable levels between cybrid lines

    • Assess biochemical traits including SDH activity, ATP content, and ROS production

This methodology enables direct comparison of functional effects between different MT-ND4L variants within an identical nuclear genetic background.

What techniques are most effective for identifying protein-protein interactions involving MT-ND4L within Complex I?

Several complementary techniques can effectively identify protein-protein interactions involving MT-ND4L within Complex I:

  • Chemical cross-linking coupled with mass spectrometry:

    • Apply membrane-permeable cross-linkers like DSS or DSG

    • Digest cross-linked complexes with proteases

    • Identify cross-linked peptides through LC-MS/MS

    • Analyze data using specialized cross-linking software

  • Proximity labeling approaches:

    • Generate MT-ND4L fusions with enzymes like BioID or APEX2

    • Allow proximity-dependent labeling of interacting proteins

    • Purify biotinylated proteins using streptavidin affinity

    • Identify interaction partners through mass spectrometry

  • Co-immunoprecipitation with specific antibodies:

    • Develop antibodies against MT-ND4L or epitope-tagged versions

    • Solubilize mitochondrial membranes with mild detergents like digitonin

    • Perform immunoprecipitation followed by Western blotting or mass spectrometry

    • Validate interactions through reciprocal co-immunoprecipitation

  • Blue Native PAGE combined with second-dimension SDS-PAGE:

    • Separate intact Complex I under native conditions

    • Perform second-dimension SDS-PAGE to resolve individual subunits

    • Identify co-migrating proteins through Western blotting or mass spectrometry

  • Computational prediction and molecular modeling:

    • Develop structural models based on sequence alignment with homologous proteins

    • Perform in silico docking studies to predict interaction interfaces

    • Validate predictions experimentally through site-directed mutagenesis

These approaches provide complementary data on MT-ND4L interactions, offering insights into its structural role within Complex I and potential mechanisms of dysfunction in disease states.

How should researchers interpret differences in electron transfer rates between wild-type and mutant MT-ND4L variants?

Interpreting differences in electron transfer rates between wild-type and mutant MT-ND4L variants requires careful consideration of multiple factors:

ParameterWild-type MT-ND4LMutant MT-ND4LPercent ChangeSignificance
NADH oxidation rateX nmol/min/mgY nmol/min/mgZ%p-value
Ubiquinone reductionX nmol/min/mgY nmol/min/mgZ%p-value
Rotenone sensitivityX% inhibitionY% inhibitionZ%p-value
ROS productionX RFU/minY RFU/minZ%p-value
ATP synthesisX nmol/min/mgY nmol/min/mgZ%p-value

This comprehensive analysis framework enables researchers to distinguish between mutations that affect specific aspects of MT-ND4L function, such as direct ubiquinone interaction versus structural roles in Complex I assembly or stability.

What criteria should be used to evaluate the pathogenicity of novel MT-ND4L variants discovered in research or clinical settings?

Evaluating the pathogenicity of novel MT-ND4L variants requires a multifaceted approach integrating computational, biochemical, and functional evidence:

  • Computational predictive methods:

    • Sequence conservation analysis across species

    • Prediction algorithms (PolyPhen-2, SIFT, MutationTaster)

    • Structural impact modeling based on homology models

    • Population frequency data from mitochondrial genome databases

  • Biochemical characterization:

    • Electron transfer activity measurements comparing wild-type and variant proteins

    • Assessment of ubiquinone binding affinity using techniques like photoaffinity labeling

    • Protein stability and assembly into Complex I analysis

    • ROS production and ATP synthesis capacity measurements

  • Transmitochondrial cybrid functional studies:

    • Generation of cybrid cell lines harboring the variant of interest

    • Comprehensive assessment of biochemical traits (SDH activity, ATP content, ROS production)

    • Growth characteristics in galactose versus glucose media

    • Stress response to metabolic and oxidative challenges

  • Clinical correlation parameters:

    • Segregation with disease in affected families

    • Tissue-specific manifestations

    • Heteroplasmy levels correlation with symptom severity

    • Response to mitochondrial-targeted therapies

  • Standardized classification framework:

Evidence CategoryStrong PathogenicityModerate PathogenicityUncertain SignificanceLikely Benign
Functional Impact>80% reduction in activity50-80% reduction20-50% reduction<20% reduction
ROS Production>200% increase100-200% increase50-100% increase<50% increase
ATP Synthesis>80% decrease50-80% decrease20-50% decrease<20% decrease
ConservationInvariant across speciesConserved in mammalsVariable in mammalsNot conserved
Population DataAbsent from controlsExtremely rare (<0.1%)Rare (<1%)Common (>1%)

This systematic approach ensures consistent evaluation of novel MT-ND4L variants, facilitating accurate classification of their clinical significance and research value.

How can researchers reconcile contradictory data when studying MT-ND4L function across different experimental systems?

Reconciling contradictory data across different experimental systems is a common challenge in MT-ND4L research that requires systematic investigation of potential sources of variation:

  • Experimental system comparison:

    • Document all differences in expression systems (bacterial, yeast, mammalian)

    • Compare purification methods and detergent effects on protein function

    • Analyze buffer compositions and assay conditions

    • Assess the presence of other Complex I subunits in each system

  • Technical validation approach:

    • Perform inter-laboratory replication of key findings

    • Use multiple complementary techniques to measure the same parameter

    • Develop robust positive and negative controls for each assay

    • Calculate minimum detectable effect sizes based on assay variation

  • Biological factors analysis:

    • Consider species-specific differences in MT-ND4L sequence and function

    • Evaluate the impact of nuclear genetic background in different cell lines

    • Assess mitochondrial DNA haplotype effects on MT-ND4L function

    • Examine tissue-specific factors that may modulate protein activity

  • Reconciliation strategies:

    • Perform meta-analysis of all available data with weighting based on methodological rigor

    • Develop integrative models that incorporate system-specific variables

    • Design critical experiments specifically to test contradictory hypotheses

    • Consider context-dependent effects that may explain apparent contradictions

  • Decision matrix for evaluating contradictory findings:

Contradiction TypePotential CausesResolution ApproachValidation Method
Activity differencesBuffer composition, detergent effectsStandardize conditions across systemsDirect comparison in identical conditions
Binding site discrepanciesExperimental technique artifactsMultiple complementary approachesMutagenesis of predicted sites
Mutation impact variationNuclear background effectsTransmitochondrial cybrid testingSame mutation in multiple backgrounds
Species-specific differencesEvolutionary divergencePhylogenetic analysisChimeric proteins with domain swapping

By systematically addressing these factors, researchers can transform apparent contradictions into deeper mechanistic insights about context-dependent functions of MT-ND4L across different experimental systems and species.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.